Genes & Development,
Journal Year:
2024,
Volume and Issue:
38(11-12), P. 473 - 503
Published: June 1, 2024
The
discovery
of
epigenetic
modulators
(writers,
erasers,
readers,
and
remodelers)
has
shed
light
on
previously
underappreciated
biological
mechanisms
that
promote
diseases.
With
these
insights,
novel
biomarkers
innovative
combination
therapies
can
be
used
to
address
challenging
difficult
treat
disease
states.
This
review
highlights
key
writers,
remodelers
control,
as
well
their
connection
with
states
recent
advances
in
associated
therapies.
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: Dec. 29, 2022
Sirtuins
(SIRTs)
are
nicotine
adenine
dinucleotide(+)-dependent
histone
deacetylases
regulating
critical
signaling
pathways
in
prokaryotes
and
eukaryotes,
involved
numerous
biological
processes.
Currently,
seven
mammalian
homologs
of
yeast
Sir2
named
SIRT1
to
SIRT7
have
been
identified.
Increasing
evidence
has
suggested
the
vital
roles
members
SIRT
family
health
disease
conditions.
Notably,
this
protein
plays
a
variety
important
cellular
biology
such
as
inflammation,
metabolism,
oxidative
stress,
apoptosis,
etc.,
thus,
it
is
considered
potential
therapeutic
target
for
different
kinds
pathologies
including
cancer,
cardiovascular
disease,
respiratory
other
Moreover,
identification
modulators
exploring
functions
these
prompted
increased
efforts
discover
new
small
molecules,
which
can
modify
activity.
Furthermore,
several
randomized
controlled
trials
indicated
that
interventions
might
affect
expression
human
samples,
supplementation
diverse
impact
on
physiological
function
participants.
In
review,
we
introduce
history
structure
family,
discuss
molecular
mechanisms
elaborate
regulatory
SIRTs
summarize
inhibitors
activators,
review
related
clinical
studies.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: March 2, 2023
Abstract
Epigenetics
regulates
gene
expression
and
has
been
confirmed
to
play
a
critical
role
in
variety
of
metabolic
diseases,
such
as
diabetes,
obesity,
non-alcoholic
fatty
liver
disease
(NAFLD),
osteoporosis,
gout,
hyperthyroidism,
hypothyroidism
others.
The
term
‘epigenetics’
was
firstly
proposed
1942
with
the
development
technologies,
exploration
epigenetics
made
great
progresses.
There
are
four
main
epigenetic
mechanisms,
including
DNA
methylation,
histone
modification,
chromatin
remodelling,
noncoding
RNA
(ncRNA),
which
exert
different
effects
on
diseases.
Genetic
non-genetic
factors,
ageing,
diet,
exercise,
interact
jointly
affect
formation
phenotype.
Understanding
could
be
applied
diagnosing
treating
diseases
clinic,
biomarkers,
drugs,
editing.
In
this
review,
we
introduce
brief
history
well
milestone
events
since
proposal
‘epigenetics’.
Moreover,
summarise
research
methods
general
mechanisms
modulation.
Furthermore,
interaction
between
genetic
or
factors.
Finally,
clinical
trials
applications
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Feb. 17, 2023
Abstract
Drug
resistance
is
mainly
responsible
for
cancer
recurrence
and
poor
prognosis.
Epigenetic
regulation
a
heritable
change
in
gene
expressions
independent
of
nucleotide
sequence
changes.
As
the
common
epigenetic
mechanisms,
DNA
methylation,
histone
modification,
non-coding
RNA
have
been
well
studied.
Increasing
evidence
has
shown
that
aberrant
regulations
contribute
to
tumor
resistance.
Therefore,
targeting
regulators
represents
an
effective
strategy
reverse
drug
In
this
review,
we
summarize
roles
addition,
as
essential
factors
modifications,
demethylases
mediate
or
genomic
modifications.
Herein,
comprehensively
describe
functions
demethylase
family
including
lysine-specific
family,
Jumonji
C-domain-containing
arginine
fully
discuss
their
regulatory
mechanisms
related
therapeutic
strategies,
small-molecule
inhibitors
small
interfering
overcome
resistance,
are
also
described.
Clinical Science,
Journal Year:
2024,
Volume and Issue:
138(13), P. 817 - 850
Published: June 26, 2024
Abstract
Optimal
vascular
structure
and
function
are
essential
for
maintaining
the
physiological
functions
of
cardiovascular
system.
Vascular
remodelling
involves
changes
in
vessel
structure,
including
its
size,
shape,
cellular
molecular
composition.
These
result
from
multiple
risk
factors
may
be
compensatory
adaptations
to
sustain
blood
function.
They
occur
diverse
pathologies,
hypertension
heart
failure
atherosclerosis.
Dynamic
endothelium,
fibroblasts,
smooth
muscle
cells,
pericytes
or
other
wall
cells
underlie
remodelling.
In
addition,
immune
macrophages
lymphocytes,
infiltrate
vessels
initiate
inflammatory
signalling.
contribute
a
dynamic
interplay
between
cell
proliferation,
apoptosis,
migration,
inflammation,
extracellular
matrix
reorganisation,
all
critical
mechanisms
Molecular
pathways
underlying
these
processes
include
growth
(e.g.,
endothelial
factor
platelet-derived
factor),
cytokines
interleukin-1β
tumour
necrosis
factor-α),
reactive
oxygen
species,
signalling
pathways,
such
as
Rho/ROCK,
MAPK,
TGF-β/Smad,
related
nitric
oxide
superoxide
biology.
MicroRNAs
long
noncoding
RNAs
crucial
epigenetic
regulators
gene
expression
We
evaluate
potential
therapeutic
targeting
clinical
translational
perspective.
summary,
remodelling,
coordinated
modification
function,
is
disease
pathology.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Sept. 16, 2024
Abstract
Histone
post-translational
modifications
(HPTMs),
as
one
of
the
core
mechanisms
epigenetic
regulation,
are
garnering
increasing
attention
due
to
their
close
association
with
onset
and
progression
diseases
potential
targeted
therapeutic
agents.
Advances
in
high-throughput
molecular
tools
abundance
bioinformatics
data
have
led
discovery
novel
HPTMs
which
similarly
affect
gene
expression,
metabolism,
chromatin
structure.
Furthermore,
a
growing
body
research
has
demonstrated
that
histone
also
play
crucial
roles
development
various
diseases,
including
cancers,
cardiovascular
infectious
psychiatric
disorders,
reproductive
system
diseases.
This
review
defines
nine
modifications:
lactylation,
citrullination,
crotonylation,
succinylation,
SUMOylation,
propionylation,
butyrylation,
2-hydroxyisobutyrylation,
2-hydroxybutyrylation.
It
comprehensively
introduces
modification
processes
these
HPTMs,
transcription,
replication,
DNA
repair
recombination,
structure,
well
involvement
promoting
occurrence
clinical
applications
targets
biomarkers.
Moreover,
this
provides
detailed
overview
HPTM
inhibitors
targeting
emerging
strategies
treatment
multiple
while
offering
insights
into
future
prospects
challenges.
Additionally,
we
briefly
introduce
techniques
field
research.
Acta Pharmaceutica Sinica B,
Journal Year:
2024,
Volume and Issue:
14(7), P. 3027 - 3048
Published: March 12, 2024
Endothelial-to-mesenchymal
transition
(EndMT)
is
a
key
driver
of
atherosclerosis.
Aerobic
glycolysis
increased
in
the
endothelium
atheroprone
areas,
accompanied
by
elevated
lactate
levels.
Histone
lactylation,
mediated
lactate,
can
regulate
gene
expression
and
participate
disease
regulation.
However,
whether
histone
lactylation
involved
atherosclerosis
remains
unknown.
Here,
we
report
that
lipid
peroxidation
could
lead
to
EndMT-induced
increasing
lactate-dependent
H3
lysine
18
(H3K18la)
vitro
vivo,
as
well
atherosclerotic
patients'
arteries.
Mechanistically,
chaperone
ASF1A
was
first
identified
cofactor
P300,
which
precisely
regulated
enrichment
H3K18la
at
promoter
SNAI1,
thereby
activating
SNAI1
transcription
promoting
EndMT.
We
found
deletion
inhibited
EndMT
improved
endothelial
dysfunction.
Functional
analysis
based
on
ApoeKOAsf1aECKO
mice
model
confirmed
involvement
endothelium-specific
deficiency
alleviated
development.
Inhibition
pharmacologic
inhibition
advanced
PROTAC
attenuated
H3K18la,
transcription,
This
study
illustrates
precise
crosstalk
between
metabolism
epigenetics
via
P300/ASF1A
molecular
complex
during
atherogenesis,
provides
emerging
therapies
for
Pharmacological Research,
Journal Year:
2025,
Volume and Issue:
212, P. 107588 - 107588
Published: Jan. 7, 2025
Atherosclerosis,
a
multifactorial
progressive
inflammatory
disease,
is
the
common
pathology
underlying
cardiovascular
and
cerebrovascular
diseases.
The
macrophage
plasticity
involved
in
pathogenesis
of
atherosclerosis.
With
advance
metabolomics
epigenetics,
metabolites/metabolic
epigenetic
modification
such
as
DNA
methylation,
histone
noncoding
RNA,
play
crucial
role
polarization
progression
Herein,
we
provide
comprehensive
review
essential
metabolic
regulation,
well
crosstalk
between
two
regulating
We
also
highlight
potential
therapeutic
strategies
via
modifications
for
atherosclerosis,
offer
recommendations
to
our
knowledge
roles
metabolic-epigenetic
context
Fundamental
studies
that
elucidate
mechanisms
by
which
regulation
influence
atherosclerosis
will
pave
way
novel
approaches.